Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $8.91 | Prev. Close $8.88 | Circuit Range N/A |
Day Range $8.89 - $9.36 | Year Range $6.21 - $11.96 | Volume 2,17,822 |
Average Traded $9.17 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $8.91 | $9.37 | +0.00% |
29-Jun-26 | $8.91 | $9.37 | +5.52% |
26-Jun-26 | $8.55 | $8.88 | +3.86% |
25-Jun-26 | $8.81 | $8.55 | -3.93% |
24-Jun-26 | $9.16 | $8.90 | -0.95% |
23-Jun-26 | $8.91 | $8.98 | -0.17% |
22-Jun-26 | $9.13 | $9.00 | -1.53% |